Clinical Trial Update: A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability of a fixed-dose combination tablet of dutasteride 0.5 mg and tamsulosin hydrochloride 0.2 mg versus co-adm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED